Time New York: Fri 30 Sep 19:44 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Puma Biotechnology (PBYI) Shares March Higher, Can It Continue?

Zacks

As of late, it has definitely been a great time to be an investor in Puma Biotechnology Inc PBYI. The stock has moved higher by 7.9% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider PBYI’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as PBYI has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.


Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.